Vectorized Antibodies for In Vivo Expression Market Insights Shaping Future Biologic Therapies
The United States represents one of the largest and most advanced markets for vectorized antibodies for in vivo expression, driven by a strong biotechnology ecosystem, substantial R&D investments, and the presence of leading pharmaceutical and gene therapy companies. Growing adoption … Read more